Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
2992 |
|
| Actual shortage: | 230 (8%) | |
| Anticipated shortage: | 21 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2732 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216717 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216720 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216723 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2017-05-30 | 2017-06-30 | 11567 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2018-05-31 | 2018-10-12 | 50964 |
| APO-OLOPATADINE | 0.1% | SOLUTION | Resolved | 2019-04-18 | 2019-06-24 | 82016 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-07-31 | 2019-08-02 | 90347 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-11-20 | 2021-09-01 | 99317 |
| APO-OLOPATADINE | 0.1% | SOLUTION | Actual shortage | 2020-06-04 | 2020-06-04 | 116551 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Actual shortage | 2024-03-27 | 2024-03-27 | 223564 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-10 | 2017-04-04 | 408 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-12 | 2017-04-04 | 674 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-09-25 | 2019-10-28 | 94744 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-09-17 | 2020-09-28 | 124353 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-08-18 | 2023-09-15 | 202409 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-02-09 | 2024-04-12 | 219180 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-02-16 | 2024-04-05 | 219840 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2017-12-14 | 2018-09-28 | 32822 |
| APO-ONDANSETRON | 4MG | TABLET | Resolved | 2018-01-08 | 2018-09-29 | 35223 |
| APO-ONDANSETRON | 8MG | TABLET | Resolved | 2018-03-13 | 2018-09-29 | 42697 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |